The guidance is welcome and was needed to provide clarity, particularly in determining the appropriate level of NHS involvement when patients are faced with decisions about treatments that are not available at taxpayers' expense.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.7748/nm.16.2.11.s20 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!